ICS/LABA combination therapy increases asthma-related pharmacy cost – News-Medical.net


MedIndia

ICS/LABA combination therapy increases asthma-related pharmacy cost
News-Medical.net
Researchers find inhaled corticosteroid and long-acting beta agonist (ICS/LABA) combination products are commonly used by patients with mild asthma,
Amoxicillin Allergy More Likely in ChildrenMedIndia

all 3 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.